chr3-190388190-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate

The NM_006580.4(CLDN16):​c.-140A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

CLDN16
NM_006580.4 5_prime_UTR

Scores

1
18

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0810
Variant links:
Genes affected
CLDN16 (HGNC:2037): (claudin 16) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. It is found primarily in the kidneys, specifically in the thick ascending limb of Henle, where it acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions. Defects in this gene are a cause of primary hypomagnesemia, which is characterized by massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. This gene and the CLDN1 gene are clustered on chromosome 3q28. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.068103194).
BP6
Variant 3-190388190-A-G is Benign according to our data. Variant chr3-190388190-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3145473.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLDN16NM_006580.4 linkuse as main transcriptc.-140A>G 5_prime_UTR_variant 1/5 ENST00000264734.3 NP_006571.2
CLDN16NM_001378492.1 linkuse as main transcriptc.-93-47A>G intron_variant NP_001365421.1
CLDN16NM_001378493.1 linkuse as main transcriptc.-93-47A>G intron_variant NP_001365422.1
CLDN16XM_047447333.1 linkuse as main transcriptc.-93-47A>G intron_variant XP_047303289.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLDN16ENST00000264734.3 linkuse as main transcriptc.-140A>G 5_prime_UTR_variant 1/51 NM_006580.4 ENSP00000264734 P1
CLDN16ENST00000456423.2 linkuse as main transcriptc.-140A>G 5_prime_UTR_variant 1/21 ENSP00000414136
CLDN16ENST00000468220.1 linkuse as main transcriptn.306+13587A>G intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1461812
Hom.:
0
Cov.:
30
AF XY:
0.00000688
AC XY:
5
AN XY:
727204
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000719
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 07, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
3.1
DANN
Benign
0.45
DEOGEN2
Benign
0.073
T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.097
N
LIST_S2
Benign
0.31
T;T
M_CAP
Benign
0.080
D
MetaRNN
Benign
0.068
T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
0.55
N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.20
N;N
REVEL
Benign
0.18
Sift
Benign
0.14
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0
B;B
Vest4
0.15
MutPred
0.11
Gain of MoRF binding (P = 0.0317);Gain of MoRF binding (P = 0.0317);
MVP
0.65
MPC
0.11
ClinPred
0.10
T
GERP RS
-0.86
Varity_R
0.029
gMVP
0.052

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-190105979; API